Document is current
Any future updates will be listed below
-
Authors
Kurinami, Noboru
Sugiyama, Seigo
Yoshida, Akira
Hieshima, Kunio
Suzuki, Tomoko
Miyamoto, Fumio
Kajiwara, Keizo
Jinnouchi, Katsunori
Jinnouchi, Hideaki https://orcid.org/0000-0002-7391-7966
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 6 August 2024
First Online: 23 September 2024
Declarations
:
: HJ has received honoraria from Novo Nordisk, Sanofi, AstraZeneca Pharmaceuticals, Astellas Pharma, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, Takeda, and Novartis Pharmaceuticals. SS has received honoraria from AstraZeneca Pharmaceuticals and Ono Pharmaceutical. The authors declare that no other potential conflicts of interest exist related to this study.
: This study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the Human Ethics Review Committee of Jinnouchi Hospital on March 26, 2018 (approval number: 2018–3-4). Informed consent or substitute for it was obtained from all patients for being included in the study.
